Cardinal Health Inc (CAH)vsCencora Inc. (COR)
CAH
Cardinal Health Inc
$207.83
-1.47%
HEALTHCARE · Cap: $48.91B
COR
Cencora Inc.
$326.91
-1.46%
HEALTHCARE · Cap: $65.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 33% more annual revenue ($325.78B vs $244.67B). CAH leads profitability with a 68.0% profit margin vs 50.0%. COR appears more attractively valued with a PEG of 0.82. COR earns a higher WallStSmart Score of 62/100 (C+).
CAH
Buy53
out of 100
Grade: C-
COR
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+13.6%
Fair Value
$259.58
Current Price
$207.83
$51.75 discount
Margin of Safety
-44.0%
Fair Value
$253.90
Current Price
$326.91
$73.01 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 68 of every $100 in revenue as profit
Strong operational efficiency at 123.0%
Safe zone — low bankruptcy risk
18.8% revenue growth
Every $100 of equity generates 134 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 118.0%
Large-cap with strong market position
Growing faster than its price suggests
Areas to Watch
Premium valuation, high expectations priced in
ROE of 0.0% — below average capital efficiency
Premium valuation, high expectations priced in
Trading at 33.3x book value
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : CAH
The strongest argument for CAH centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 68.0% and operating margin at 123.0%. Revenue growth of 18.8% demonstrates continued momentum.
Bull Case : COR
The strongest argument for COR centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 50.0% and operating margin at 118.0%. PEG of 0.82 suggests the stock is reasonably priced for its growth.
Bear Case : CAH
The primary concerns for CAH are P/E Ratio, Return on Equity.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Price/Book, Free Cash Flow. A P/E of 40.2x leaves little room for execution misses.
Key Dynamics to Monitor
CAH profiles as a growth stock while COR is a mature play — different risk/reward profiles.
COR carries more volatility with a beta of 0.65 — expect wider price swings.
CAH is growing revenue faster at 18.8% — sustainability is the question.
CAH generates stronger free cash flow (555M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 53/100), backed by strong 50.0% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cardinal Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cardinal Health, Inc. is an American multinational health care services company.
Visit Website →Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?